Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance W Wu, JL Klockow, M Zhang, F Lafortune, E Chang, L Jin, Y Wu, ... Pharmacological research 171, 105780, 2021 | 303 | 2021 |
Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication J Theruvath, M Menard, BAH Smith, MH Linde, GL Coles, GN Dalton, ... Nature medicine 28 (2), 333-344, 2022 | 137 | 2022 |
In vivo imaging of nanoparticle-labeled CAR T cells L Kiru, A Zlitni, AM Tousley, GN Dalton, W Wu, F Lafortune, A Liu, ... Proceedings of the National Academy of Sciences 119 (6), e2102363119, 2022 | 56 | 2022 |
Lipid peroxidation plays an important role in chemotherapeutic effects of temozolomide and the development of therapy resistance in human glioblastoma W Wu, Y Wu, K Mayer, C von Rosenstiel, J Schecker, S Baur, S Würstle, ... Translational oncology 13 (3), 100748, 2020 | 46 | 2020 |
Aldehyde dehydrogenase 1A3 (ALDH1A3) is regulated by autophagy in human glioblastoma cells W Wu, J Schecker, S Würstle, F Schneider, M Schönfelder, J Schlegel Cancer letters 417, 112-123, 2018 | 44 | 2018 |
Temozolomide induces autophagy in primary and established glioblastoma cells in an EGFR independent manner S Würstle, F Schneider, F Ringel, J Gempt, F Lämmer, C Delbridge, ... Oncology Letters 14 (1), 322-328, 2017 | 39 | 2017 |
Deguelin‐induced blockade of PI 3K/protein kinase B/MAP kinase signaling in zebrafish and breast cancer cell lines is mediated by down‐regulation of fibroblast growth factor … W Wu, Y Hai, L Chen, RJ Liu, YX Han, WH Li, S Li, S Lin, XR Wu Pharmacology research & perspectives 4 (2), e00212, 2016 | 24 | 2016 |
Immunohistochemically characterized intratumoral heterogeneity is a prognostic marker in human glioblastoma F Liesche-Starnecker, K Mayer, F Kofler, S Baur, F Schmidt-Graf, ... Cancers 12 (10), 2964, 2020 | 23 | 2020 |
Ascorbic Acid and Iron Supplement Treatment Improves Stem Cell–Mediated Cartilage Regeneration in a Minipig Model AJ Theruvath, EE Mahmoud, W Wu, H Nejadnik, L Kiru, T Liang, S Felt, ... The American journal of sports medicine 49 (7), 1861-1870, 2021 | 20 | 2021 |
Instant labeling of therapeutic cells for multimodality imaging H Nejadnik, KO Jung, AJ Theruvath, L Kiru, A Liu, W Wu, T Sulchek, ... Theranostics 10 (13), 6024, 2020 | 18 | 2020 |
Theranostic nanoparticles enhance the response of glioblastomas to radiation W Wu, JL Klockow, S Mohanty, KS Ku, M Aghighi, S Melemenidis, Z Chen, ... Nanotheranostics 3 (4), 299, 2019 | 17 | 2019 |
Correlation of the quantitative level of MGMT promoter methylation and overall survival in primary diagnosed glioblastomas using the quantitative MethyQESD method C von Rosenstiel, B Wiestler, B Haller, F Schmidt-Graf, J Gempt, ... Journal of clinical pathology 73 (2), 112-115, 2020 | 12 | 2020 |
ALDH1-Mediated Autophagy Sensitizes Glioblastoma Cells to Ferroptosis JS Yang Wu 1, Helena Kram 1, Jens Gempt 2, Friederike Liesche-Starnecker 3 ... Cells 11 (24), 4015, 2022 | 9 | 2022 |
Multimodal In Vivo Tracking of Chimeric Antigen Receptor T Cells in Preclinical Glioblastoma Models WE Wu, E Chang, L Jin, S Liu, CH Huang, R Kamal, T Liang, NM Aissaoui, ... Investigative Radiology, 10.1097, 2023 | 7 | 2023 |
Tumor protease-activated theranostic nanoparticles for MRI-guided glioblastoma therapy HEDL Ching-Hsin Huang, Edwin Chang, Li Zheng, Joe Gerald Jesu Raj, Wei Wu ... Theranostics 13 (6), 2023 | 6 | 2023 |
In vivo evaluation of near-infrared fluorescent probe for TIM3 targeting in mouse glioma M Zhang, Q Zhou, C Huang, CT Chan, W Wu, G Li, M Lim, SS Gambhir, ... Molecular imaging and biology 24 (2), 280-287, 2022 | 3 | 2022 |
Anti-GD2 antibody disrupts GD2: Siglec-7 interactions and synergizes with CD47 blockade to mediate tumor eradication J Theruvath, M Menard, BAH Smith, MH Linde, GL Coles, W Wu, L Kiru, ... BioRxiv, 2021.03. 19.436221, 2021 | 3 | 2021 |
MegaPro, a clinically translatable nanoparticle for in vivo tracking of stem cell implants in pig cartilage defects V Suryadevara, MJ Hajipour, LC Adams, NM Aissaoui, A Rashidi, L Kiru, ... Theranostics 13 (8), 2710, 2023 | 2 | 2023 |
ALDH1A1 and ALDH1A3 paralogues of aldehyde dehydrogenase 1 control myogenic differentiation of skeletal muscle satellite cells by retinoic acid-dependent and-independent mechanisms L Steingruber, F Krabichler, S Franzmeier, W Wu, J Schlegel, M Koch Cell and Tissue Research 394 (3), 515-528, 2023 | 1 | 2023 |
Noninvasive strategies of cell-tracking in vivo Y Han, Y Li, WE Wu, Z Liu TrAC Trends in Analytical Chemistry, 117616, 2024 | | 2024 |